VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
39 hedge funds and large institutions have $1.73M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Holders
39
Holding in Top 10
–
Calls
$532K
Puts
$1K
Top Buyers
| 1 | +$70.4K | |
| 2 | +$42.6K | |
| 3 | +$23K | |
| 4 |
Goldman Sachs
New York
|
+$17.8K |
| 5 |
Morgan Stanley
New York
|
+$17.1K |
Top Sellers
| 1 | -$41.7K | |
| 2 | -$41.3K | |
| 3 | -$29K | |
| 4 |
HF
HRT Financial
New York
|
-$15K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7.97K |